We recommend that you upgrade to the latest version of your browser.

Can Norway Build a Medical Industry Like Denmark and Sweden?

Professor Kristina Haugaa, cardiologist and leader of ProCardio Center for innovation, believes Norway has the ideal conditions to develop a thriving health industry similar to Novo Nordisk and AstraZeneca. With vast health data, strong public systems, and cutting-edge research, Norway’s “gold” could fuel new breakthroughs in medical care and industry.

Published 8/8/2025
Portrait of Kristina Haugaa

Photo: Bildmakerna

Professor and cardiologist Kristina Haugaa will participate as a speaker and panelist at Arendalsuka.

At the upcoming event “How Can Medical Research Boost Norwegian and European Competitiveness?” Haugaa and other leaders will discuss how to overcome challenges in turning research into marketable innovations. Key barriers include lack of risk capital and business expertise, as well as cultural hurdles within academia.

The goal is clear: to unlock Norway’s potential for value creation, jobs, and global competitiveness in health innovation.

The summary was based on the UiO press release and prepared with assistance from OpenAI ChatGPT.